Clinical Trial Details
EORTC-30897
Back to Clinical Trials Database
Phase II study of Mitomycin C and intravesical immunotherapy with BCG-RIVM in recurrent superficial transitional cell carninoma of the bladder
Trial Status | All trial activities ended |
---|---|
Dates |
Date of activation: 01-Mar-1990 Date Step1 close: 02-Jul-1992 |
Data management at EORTC | Yes |
Design |
Phase 2 Randomized open label |
Targeted Sample size | EORTC Groups: 24 |
Treatment | |
Study Staff | |
Type of cancer | |
Participating groups | |
Protocol summary | http://clinicaltrials.gov/study/ |
NCT number |